NumFin

Fisher & Paykel Healthcare Corporation Limited

符号: FPH.AX

ASX

23.66

AUD

今天的市场价格

  • 61.8116

    市盈率

  • 3.7087

    PEG比率

  • 13.82B

    MRK市值

  • 0.01%

    DIV收益率

Fisher & Paykel Healthcare Corporation Limited (FPH-AX) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Fisher & Paykel Healthcare Corporation Limited (FPH.AX). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Fisher & Paykel Healthcare Corporation Limited 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

balance-sheet.row.cash-and-short-term-investments

0113.3268.5347.2
140.3
135.1
142.1
75.5
28.5
13.6
10.4
7.7
6.3
6.1
6.9
5.5
5.3
7.7
28.6
37.1
47.6
48.3
73.3
102.2

balance-sheet.row.short-term-investments

00.5185.3257.7
75.3
88.8
112.1
19.4
11.5
23.8
33.1
28.4
21
14.9
21.4
6.3
2.9
0
12
14
17
35
0
0

balance-sheet.row.net-receivables

0237.9169.2210.5
216.3
152.9
138.9
120.7
120.3
107.4
93.4
81.6
77.1
79.6
71.4
81
60.3
58.5
55.4
54.6
49.1
59
41.8
34.1

balance-sheet.row.inventory

0342.4332.4248.8
141.9
130.7
117.9
123.7
109.2
96.1
94.5
89.1
84.4
80.1
71.8
69.9
50.8
46.7
36.2
30.9
24.1
21.9
19.2
18.3

balance-sheet.row.other-current-assets

031.152.239.4
4
18.4
0
1.9
1.7
1.8
1.3
1.1
0.4
0.3
1.8
7.2
8.6
5.3
4.5
0.5
0.3
4.6
6.3
8.6

balance-sheet.row.total-current-assets

0724.6822.4846
502.4
437.1
399
319.9
257.9
243.3
235
215.2
195
186.5
180.1
172.7
129.6
118.2
125.3
127.7
122.5
133.8
140.6
163.1

balance-sheet.row.property-plant-equipment-net

01074.7887.2811.1
712.2
577.4
448
389.6
351.6
367.4
349.8
346.7
311.6
254.3
233.3
204.6
186.5
141.9
128.3
82.9
71.5
71.4
64.9
58.9

balance-sheet.row.goodwill

0000
0
0
0
0
0
1.4
1.4
1.4
1
1
1
1
1
0.6
1
1.4
1.8
2.2
0
3

balance-sheet.row.intangible-assets

080.180.473.6
71.6
59
47.4
40.8
32.3
21
9
7.2
5.4
5.4
4.9
4.5
4.3
2.2
2.3
2.4
4
3.9
2.6
0

balance-sheet.row.goodwill-and-intangible-assets

080.180.473.6
71.6
59
47.4
40.8
32.3
22.4
10.4
8.6
6.4
5.4
4.9
4.5
4.3
2.9
3.3
3.8
4
3.9
2.6
3

balance-sheet.row.long-term-investments

093.584.2102.6
15.9
47.6
37.1
24.4
23.5
13.1
17.2
27.9
37.4
44.9
34.2
11
1.5
0
0
2.8
11.4
0
-3.1
0

balance-sheet.row.tax-assets

090.477.474.8
87.9
37.3
32.6
30.1
26.8
19.9
14.7
11.6
9.7
8.8
11
16.8
8.7
10.3
10.3
13.2
13.7
7.8
3.1
0

balance-sheet.row.other-non-current-assets

0000
0
0
0
0
0
3.6
3.3
8.6
11.9
17.7
11.6
4.2
1.1
1.4
0.3
0
0.9
11.8
7.3
11.7

balance-sheet.row.total-non-current-assets

01338.71129.21062
887.6
721.4
565.1
484.9
434.2
426.5
395.4
403.4
377
331.1
295
241.1
202.1
156.5
142.1
102.7
101.7
95
74.8
73.5

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

02063.41951.61908
1390
1158.5
964.1
804.7
692.1
669.8
630.3
618.6
572.1
517.6
475.1
413.7
331.7
274.7
267.5
230.3
224.2
228.8
215.3
236.7

balance-sheet.row.account-payables

040.249.852.1
67.1
52.9
30.8
26.9
33.4
27.7
23.2
21.1
22.5
21.1
22.8
23.7
14.7
15.9
19.2
15.1
10.8
8.7
8.4
8.5

balance-sheet.row.short-term-debt

019.915.724.5
89.3
16.6
28.1
19.3
14.7
14.2
45.8
17.1
80.2
17.1
24.5
23.4
65
40.8
23.8
8.1
6.3
3.1
7.5
8.6

balance-sheet.row.tax-payables

06.229.5137.6
34.3
23.4
20.7
13.5
17.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

07458.457.7
21.3
66.2
49.4
36.6
42.3
51.3
63.6
117.4
34.5
81.9
59.6
97.5
21.1
0
0
0
1.9
0
1.5
1.7

Deferred Revenue Non Current

042.500
0
0
0
0
0
0.3
0.7
2.9
3.1
3
2.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0204.9186.4178.9
133.4
84.1
88.2
73.7
69.6
7.5
4.7
24.5
21.6
3.9
4.1
10
2.8
11.4
8.7
7.3
10.2
20.1
11.2
4.8

balance-sheet.row.total-non-current-liabilities

0151114.3116.4
122.6
104.7
80.2
65
68.2
81.5
95.4
155.3
73.3
120.1
84.1
115.6
25.6
1
1.1
0.9
2.5
1.2
1.7
21.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

042.522.526.7
21.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0422.2395.8509.5
446.7
281.8
248
198.5
203.2
198.6
224.2
246.4
223.9
204.3
181.9
209.4
136
81.2
63.5
38.3
32.9
35.9
43.5
84.6

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0287.3246.7231.1
221.8
212.2
189.4
168.1
149.5
145.9
120.4
91.3
63.3
38.7
13
4.1
3.6
193.5
204
192
170.6
172.7
171.9
152.1

balance-sheet.row.retained-earnings

01123.61094.1946.4
664.8
527.3
439.5
358.3
295.9
266.8
224.5
194.9
184
184.7
196.1
187.7
188.7
0
0
0
20.6
20.1
171.9
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0233.2219.8223.1
60.2
139
90
81.3
45.6
58.5
61.2
86
100.8
89.9
84.1
12.5
3.3
-53.9
-0.2
-3.6
-4
-2
-17.4
0

balance-sheet.row.other-total-stockholders-equity

0-3.1-4.7-2
-3.5
-1.7
-2.8
-1.5
-2.2
0
0
0
0
0
0
0
0
53.9
0.2
3.6
4
2
-154.5
0

balance-sheet.row.total-stockholders-equity

01641.11555.91398.5
943.2
876.8
716.1
606.3
488.9
471.2
406.1
372.2
348.2
313.3
293.2
204.3
195.7
193.5
204
192
191.2
192.8
171.9
152.1

balance-sheet.row.total-liabilities-and-stockholders-equity

02063.41951.61908
1390
1158.5
964.1
804.7
692.1
669.8
630.3
618.6
572.1
517.6
475.1
413.7
331.7
274.7
267.5
230.3
224.2
228.8
215.3
236.7

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

01641.11555.91398.5
943.2
876.8
716.1
606.3
488.9
471.2
406.1
372.2
348.2
313.3
293.2
204.3
195.7
193.5
204
192
191.2
192.8
171.9
152.1

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

093.5269.5360.4
91.1
136.4
149.2
43.8
35
36.9
50.4
56.2
58.5
59.8
55.7
17.3
4.3
0
12
14
17
35
-3.1
0

balance-sheet.row.total-debt

0136.596.6108.9
131.9
82.9
77.5
55.9
57
65.5
109.4
134.5
114.7
99
84.1
121
86.1
40.8
23.8
8.1
8.2
3.1
9
10.3

balance-sheet.row.net-debt

023.213.319.4
66.9
36.6
47.5
-0.2
40.1
51.9
98.9
126.8
108.5
92.9
77.2
115.5
80.9
33.1
7.3
-15
-22.4
-10.2
-64.3
-91.9

现金流量表

在 Fisher & Paykel Healthcare Corporation Limited 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

cash-flows.row.net-income

0234.3349.1482
278.3
200.9
178.9
155
129.5
0
97.1
77.1
64.1
52.5
71.6
62.2
35.3
57.6
70
61.4
54.7
72.9
48.1
9.7

cash-flows.row.depreciation-and-amortization

092.788.978.2
59.1
40
41.9
35.8
31.8
0
28
21.2
17.8
16.2
13.5
14.3
14.1
13.3
9.5
8.1
7.3
8.4
6.1
5.8

cash-flows.row.deferred-income-tax

04.5-6.3-54.3
-23.2
-3.2
0.5
-1.8
-16.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-250.1-216.3-214.7
-145.6
-85
-84.1
-78.7
-90.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-64.8-38.4-58.4
-27.4
-1.2
6.5
-11.3
-16.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-receivables

0-40.548.6-4.7
-62.8
-11.3
-15.4
3.9
-23.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-6.5-81.8-114.1
-10.1
-10.3
9
-12.9
-22.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

0-17.8-5.360.4
45.4
16.7
6.2
1.8
18.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0000
0
3.6
6.7
-4.2
10.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

0206.4123.4342.2
170.2
91.7
89.3
-0.3
2.6
0
-27.4
-28.9
-7.9
-16.5
21.4
-25.2
-11
-70.9
2.9
-3.2
-9.5
-81.4
1.9
-15.5

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-197.8-157.3-169.8
-165.3
-128
-92.8
-57.7
-59.4
-53.6
-31.9
-62
-67.5
-43.3
-48.3
-22.4
-13.5
-28.7
-53.6
-16.8
-9.5
-16.5
-13.2
0

cash-flows.row.acquisitions-net

0000
0
0.1
0.2
0.1
0
0
0
0
0
0
0
0
0
1.1
1.1
0.9
0
0
0
0

cash-flows.row.purchases-of-investments

000-186.3
0
0
-94
0
0
0
0
0
0
0
0
0
0
-7
-22
-55.3
-80.8
-149.1
0
0

cash-flows.row.sales-maturities-of-investments

0187.274.40
14.5
7.2
0
0
0
0
0
0
0
0
0
0
0
18.8
23.9
58.3
98.5
114.5
299.3
0

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
-14.3
0
0.1
0
0.1
0.1
0
0
-1
-1.1
-1
0
0.1
-5.6
0

cash-flows.row.net-cash-used-for-investing-activites

0-10.6-82.9-356.1
-150.8
-120.7
-186.7
-57.6
-59.3
-53.6
-31.9
-62
-67.5
-43.2
-48.2
-22.4
-13.5
-16.7
-51.7
-13.8
8.2
-51
280.5
0

cash-flows.row.debt-repayment

0-9.4-0.1-45.3
-5
-0.6
-20.3
0
-7.3
-50.2
-30.8
-68.6
-16.8
-27.8
-47.2
-8.6
-12.5
0
-68.5
0
0
-15.7
-14.8
0

cash-flows.row.common-stock-issued

02.833.2
2.2
0.3
0.8
0.7
0.8
1.6
27.1
26.1
23.8
23.3
7
0.2
1.1
0.9
1
1.2
2.3
3.8
30.5
0

cash-flows.row.common-stock-repurchased

00.9146.1
0.3
0
0
0
0
5
8.8
86.6
38.2
35.1
17.6
37
-12.3
0
-5.1
-8
-2.2
0
-212
0

cash-flows.row.dividends-paid

0-183.2-208.3-166.7
-141.8
-110
-96.4
-81.9
-61.5
-47.9
-72.1
-71.1
-70.2
-68.7
-68.1
-66.3
-68
-68.5
-62
-58.7
-56.1
-52.8
-79
0

cash-flows.row.other-financing-activites

04.3-14-10.2
-9.7
1.7
41.5
0.7
0.6
5.5
0.3
0.6
0.6
0.6
0.5
0.6
55.8
19.6
84
0
0
10.7
-2.4
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-184.5-218.4-172.9
-154
-108.6
-74.4
-80.4
-67.4
-91
-66.7
-26.5
-24.6
-37.5
-90.3
-37.1
-35.8
-48
-50.7
-65.5
-56
-54.1
-277.6
0

cash-flows.row.effect-of-forex-changes-on-cash

02.40.2-1
-1.2
0.6
1.9
0.2
-1.2
1
0.2
1
0.7
-0.2
0.1
0.5
-0.6
-0.4
0.1
-0.2
-0.4
-0.7
-0.3
0

cash-flows.row.net-change-in-cash

030-6.224.5
18.7
16.3
-26.1
39.2
17.4
3.2
5.7
-1
2.6
-9.9
-0.9
3.1
-5.6
-8.8
-5.8
-7.4
12
-59.8
70.3
0

cash-flows.row.cash-at-end-of-period

0113.383.389.5
65
46.3
30
56.1
16.9
-0.5
-3.8
-9.4
-8.4
-11
-1.1
-0.2
-3.3
2.3
11
16.8
24.3
12.2
72
0

cash-flows.row.cash-at-beginning-of-period

083.389.565
46.3
30
56.1
16.9
-0.5
-3.8
-9.4
-8.4
-11
-1.1
-0.2
-3.3
2.3
11
16.8
24.3
12.2
72
1.7
0

cash-flows.row.operating-cash-flow

0222.9300.4575
311.3
243.2
233.1
177.4
130.5
144
97.6
69.3
74
52.2
106.5
51.3
38.4
56.3
82.4
66.4
52.5
46
56.1
0

cash-flows.row.capital-expenditure

0-197.8-157.3-169.8
-165.3
-128
-92.8
-57.7
-59.4
-53.6
-31.9
-62
-67.5
-43.3
-48.3
-22.4
-13.5
-28.7
-53.6
-16.8
-9.5
-16.5
-13.2
0

cash-flows.row.free-cash-flow

025.2143.1405.1
146
115.2
140.2
119.7
71.1
90.4
65.8
7.3
6.5
8.9
58.3
28.9
24.9
27.6
28.8
49.6
42.9
29.5
42.9
0

利润表行

Fisher & Paykel Healthcare Corporation Limited 的收入与上期相比变化了 NaN%。据报告, FPH.AX 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

income-statement-row.row.total-revenue

01486.91521.31791.4
1233.4
1029.3
907.1
796.8
738.7
644
568.6
507.3
466.7
467.7
474.8
485.5
346
349.2
289.5
241.1
214.9
208.4
213.3
192.8

income-statement-row.row.cost-of-revenue

0601.6582.6667.2
414.5
340.4
310.7
278.6
265.2
261.4
258
248.4
241.7
228.4
231.9
212.1
177.8
149.1
121.4
67.2
62.6
67.6
65.8
0

income-statement-row.row.gross-profit

0885.3938.71124.2
819
688.9
596.4
518.2
473.5
382.6
310.6
258.8
225.1
239.3
242.8
273.4
168.2
200.1
168.2
173.9
152.3
140.9
147.4
192.8

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-7.640.232.4
-16.8
3.3
21.4
31.3
2
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
12
10.7
76
-111.6
-50

income-statement-row.row.operating-expenses

0567.4506.8490.4
442.2
388.6
348
325.6
284.8
277.5
255.5
223.9
207.2
203.2
190.3
164.5
138.2
131
108.6
92.4
81.6
75.4
6.1
63.3

income-statement-row.row.cost-and-expenses

01168.91089.41157.6
856.7
729.1
658.7
604.2
550
538.9
513.5
472.3
448.8
431.6
422.2
376.6
315.3
280.1
341.8
159.7
206.8
210.6
139.1
63.3

income-statement-row.row.interest-income

02.42.41.4
2.1
3.2
1.5
0.4
0.1
0.1
0.1
0.2
0.3
0.6
0.7
1.3
0.7
0.8
1.2
1.6
2.4
3.5
1.3
0.2

income-statement-row.row.interest-expense

06.34.54.6
3.8
2.4
3.5
3.5
8.2
11.5
7.8
4.9
0.8
5.5
-3.3
18.6
4.5
2.9
0.8
0.3
0.4
0.5
1.6
2.2

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1135.126.6
-17.9
-25.4
-1.2
21.3
-12
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
10.1
10.3
45.8
-112
-50

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-7.640.232.4
-16.8
3.3
21.4
31.3
2
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
12
10.7
76
-111.6
-50

income-statement-row.row.total-operating-expenses

0-1135.126.6
-17.9
-25.4
-1.2
21.3
-12
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
10.1
10.3
45.8
-112
-50

income-statement-row.row.interest-expense

06.34.54.6
3.8
2.4
3.5
3.5
8.2
11.5
7.8
4.9
0.8
5.5
-3.3
18.6
4.5
2.9
0.8
0.3
0.4
0.5
1.6
2.2

income-statement-row.row.depreciation-and-amortization

092.788.978.2
59.1
40
41.9
35.8
31.8
0
28
21.2
17.8
16.2
13.5
14.3
14.1
13.3
9.5
8.1
7.3
8.4
6.1
5.8

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0318431.9633.8
376.8
300.2
248.4
192.6
188.7
201.9
55.1
34.9
17.9
36.1
52.6
108.9
30.7
69.1
69.2
81.5
70.6
65.4
75.2
129.6

income-statement-row.row.income-before-tax

0307467660.4
358.9
274.8
247.2
213.9
176.8
158.8
136.7
109.4
92.3
92.8
106.8
85
54.3
87.5
104.4
91.6
80.9
111.2
93.9
16.8

income-statement-row.row.income-tax-expense

072.7117.9178.4
80.6
73.9
68.3
58.9
47.3
45.6
39.6
32.3
28.2
40.3
35.2
22.8
19
29.9
34.5
91.6
80.9
111.2
93.9
16.8

income-statement-row.row.net-income

0250.3376.9524.2
287.3
209.2
190.2
169.2
143.4
113.2
97.1
77.1
64.1
52.5
71.6
62.2
35.3
57.6
70
61.4
54.7
72.9
48.1
9.7
类似股票
您可能还对以下内容感兴趣：
CNVVF
ConvaTec Group Plc.
3.2 USD
PNK
300753.SZ
Jiangsu Apon Medical Technology Co., Ltd..
13.2 CNY
SHZ
BLCO
Bausch + Lomb Corporation.
15.29 USD
NYSE
137310.KS
SD BioSensor, Inc.
10740 KRW
KSC
YPHDF
Ypsomed Holding AG.
362 USD
PNK
INFU
InfuSystem Holdings, Inc..
7.56 USD
AMEX
688289.SS
Sansure Biotech Inc..
20.69 CNY
SHH
7780.T
Menicon Co., Ltd..
1516.5 JPY
JPX
ALC.SW
Alcon Inc..
72.94 CHF
SIX
8086.T
Nipro Corporation.
1256 JPY
JPX
6929.HK
OrbusNeich Medical Group Holdings Limited.
4.42 HKD
HKSE

常见问题

什么是 Fisher & Paykel Healthcare Corporation Limited (FPH.AX) 总资产是多少？

Fisher & Paykel Healthcare Corporation Limited (FPH.AX) 总资产为 2063359237.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 0.601.

什么是公司自由现金流？

自由现金流为 0.051.

什么是企业净利润率？

净利润率为 0.153.

企业总收入是多少？

总收入为 0.219.

什么是 Fisher & Paykel Healthcare Corporation Limited (FPH.AX) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 250300000.000.

公司总债务是多少？

债务总额为 136465310.000.

营业费用是多少？

运营支出为 567388691.000.

公司现金是多少？

企业现金为 0.000.